[口服雌孕激素制剂治疗女性中抗凝血酶III（发色底物法）和纤维蛋白降解产物的测定]
[Determination of antithrombin III (chromogenic substrates) and FDP in women in treatment with oral estroprogestin agents].
作者信息
Gibelli A, Giarola P, Ghessi A, Rocchini P M
出版信息
Minerva Med. 1978 Apr 14;69(18):1241-4.
PMID:662152
Abstract
In 280 women, in fertile age, 133 of whom represented the control group, FDP and antithrombin III with the method of chromogenic substrates were determined. In 147 women, who were taking, for variable period of time, oral estroprogestinic drugs, a significant diminution of antithrombin III was found. No significant differences for FDP were observed.
摘要
在280名育龄妇女中，其中133名作为对照组，采用发色底物法测定了纤维蛋白降解产物（FDP）和抗凝血酶III。在147名服用不同时间段口服雌孕激素药物的妇女中，发现抗凝血酶III显著降低。未观察到FDP有显著差异。
Zotero 插件